CCNY and renal carcinoma: Therefore, in summary, we found that fisetin inhibits the epigenetic mechanism in renal cancer stem cells, that is, fisetin inhibits TET1 expression and reduces 5hmC modification in specific loci in the promoters of CCNY/CDK16 in renal cancer stem cells.